...
首页> 外文期刊>The Internet Journal of Infectious Diseases >A Multiple Dose Immunisation Protocol Suitable For Edible Vaccines
【24h】

A Multiple Dose Immunisation Protocol Suitable For Edible Vaccines

机译:适用于食用疫苗的多剂量免疫方案

获取原文

摘要

Frequent administration of oral immunisation has proven to be more successful than single administration. The frequency of feeding edible vaccines, however, is limited by the maximal oral intake, the lack of nutritional value and the possible presence of toxic ingredients. Therefore, we designed a protocol in which the animals received multiple immunisations on three alternating days ('triple dose') and the protocol was compared to single immunisations. Mice were immunised via intragastric (IG) gavage with ovalbumin (OVA) mixed with cholera toxin (CT) and the effects on systemical and local immune responses were determined. Serum IgG1 and IgA titres against OVA after oral boost immunisation given three weeks after primary immunisation were significantly higher after 'triple dose' than after 'single dose' immunisation. Faecal IgA was detected only after 'triple dose' boost immunisation. A second boost did not further increase serum IgG1 and faecal IgA. Antibody responses against CT were also elicited and again, boost immunisations did not further increase this response. We concluded that oral immunisation with multiple doses was more effective than 'single dose' immunisation and it seems practical and efficient for edible vaccines. Introduction Several factors affect the immune response upon oral administration of antigen and a few can be manipulated [1].One of the most General complicating factors are degradation of the antigen in the gastro-intestinal tract and the induction of a state of oral tolerance [2,3]. Furthermore, the nature of the antigen strongly determines the outcome of oral immunisation. Oral administration of live pathogens revealed in many cases significant mucosal and systemic immune responses [4]. Oral immunisation with non-living pathogens, subunits or peptides, however, is often inefficient and requires multiple administrations with large amounts of antigen and adjuvant [5]. Another important factor is the immunisation schedule. Chalacombe [6] found that a weekly immunisation did not result in significant responses. Serial immunisations on consecutive days, however, induced sIgA. These and other data suggested that frequency and timing of immunisation are important. Detailed study on differences between single dose immunisation and multiple dose immunisation on the development of IgA and IgG1 antibodies and their course in time after priming and booster immunisation are not described yet. The goal of the present study was to establish an effective oral immunisation protocol applicable for edible vaccines for which the frequency of feeding is limited by the maximal possible oral intake. Materials and Methods Mice Swiss female mice (6 to 8 weeks old) were obtained from Charles River (Sulzfield, Germany) and housed per groups under conventional conditions. All mice were raised and kept on an OVA free diet. All animal experiments were held under auspices of the ID-Lelystad B.V. Animal Experimentation Committee according to the Dutch Law on Animal Experimentation. Antigen preparation and immunisation The antigen preparation tested consisted of 10 mg of ovalbumin (OVA; Grade V, A-5503, Sigma) mixed with 5 μg cholera toxin (CT; C-8052, Sigma) dissolved in 0.4 ml saline. Mice fasted overnight (water was provided ad libitum) and were immunised orally by intragastric intubation with OVA plus CT on Day 0, 21, and 42 (‘single dose') or on Day 0, 2, 4, 21, 23, 25, 42, 44, and 46. Collection of faeces and serum samples Pre-immune tail blood serum and faeces samples were collected before the first immunisation and on Day 14, 35, and 49. Fresh faeces pellets were immediately frozen at –20 oC. Before testing, faeces pellets were treated as described elsewhere to prevent degradation [7]. Detection of anti-OVA and anti-CT antibodies High binding ELISA plates (Greiner, Nürtingen, Germany) were coated overnight at 4oC with 100 μg ml-1 OVA or 2 μg ml-1 CT dissolved in PBS. ELISA was performed as described earlier [7]. Antibody
机译:口服免疫的频繁给药已证明比单次给药更成功。但是,食用可食疫苗的频率受到最大口服摄入量,缺乏营养价值以及可能存在有毒成分的限制。因此,我们设计了一种方案,其中动物在每隔三天接受多次免疫(“三倍剂量”),并将该方案与单次免疫进行比较。通过将卵清蛋白(OVA)与霍乱毒素(CT)混合的胃内(IG)管对小鼠进行免疫,并确定其对全身和局部免疫应答的影响。初次免疫后三周口服加强免疫后,针对OVA的血清IgG1和IgA滴度在“三倍剂量”后明显高于“单剂量”免疫后。仅在“三倍剂量”加强免疫后才检测到粪便IgA。第二次加强免疫没有进一步增加血清IgG1和粪便IgA。还引起了针对CT的抗体反应,再次,加强免疫并没有进一步增加这种反应。我们得出的结论是,多剂量口服免疫比“单剂量”免疫更有效,对于食用疫苗似乎是切实可行和有效的。引言有几种因素会影响口服抗原后的免疫反应,有些则可以操纵[1]。最普遍的复杂因素之一是胃肠道中抗原的降解和诱导口腔耐受状态[ 2,3]。此外,抗原的性质强烈决定了口服免疫的结果。口服活病原体在许多情况下显示出明显的粘膜和全身免疫反应[4]。然而,用无生命的病原体,亚基或肽进行的口服免疫通常效率低下,需要多次与大量抗原和佐剂一起给药[5]。另一个重要因素是免疫计划。 Chalacombe [6]发现,每周一次的免疫接种不会导致明显的反应。然而,连续几天的连续免疫接种诱导了sIgA。这些和其他数据表明免疫的频率和时间很重要。关于IgA和IgG1抗体的发展及其在初免和加强免疫后的时间变化的单剂量免疫和多剂量免疫之间的差异的详细研究尚未描述。本研究的目的是建立适用于可食用疫苗的有效口服免疫方案,该方案的进食频率受到最大可能的口服摄入量的限制。材料和方法小鼠瑞士雌性小鼠(6至8周大)从Charles River(德国苏尔兹菲尔德)获得,在常规条件下按组饲养。饲养所有小鼠并保持无OVA饮食。根据荷兰动物实验法,所有动物实验均在ID-Lelystad B.V.动物实验委员会的主持下进行。抗原制剂和免疫所测试的抗原制剂由10 mg卵清蛋白(OVA; V,A-5503,Sigma)与5μg溶于0.4 ml盐水的霍乱毒素(CT; C-8052,Sigma)混合组成。小鼠禁食过夜(随意提供水),并在第0、21和42天(“单次剂量”)或第0、2、4、21、23、25天通过OVA + CT胃内插管进行口服免疫, 42、44和46.粪便和血清样品的收集首次免疫前以及第14、35和49天,收集了免疫前的尾部血清和粪便样品。新鲜的粪便颗粒立即冷冻在–20 oC。在测试之前,按照其他地方的说明处理粪便颗粒以防止降解[7]。抗OVA和抗CT抗体的检测将高结合度的ELISA板(Greiner,Nürtingen,德国)在4oC下用溶于PBS的100μgml-1 OVA或2μgml-1 CT包被过夜。如先前所述[7]进行ELISA。抗体

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号